Vor Biopharma
VOR
VOR
60 hedge funds and large institutions have $134M invested in Vor Biopharma in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.02% less ownership
Funds ownership: 89.06% → 88.04% (-1%)
Holders
60
Holding in Top 10
3
Calls
$8K
Puts
–
Top Buyers
| 1 | +$804K | |
| 2 | +$601K | |
| 3 | +$325K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$103K |
| 5 |
Barclays
London,
United Kingdom
|
+$101K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$766K | |
| 3 | -$317K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$72.5K |
| 5 |
Squarepoint
New York
|
-$33.3K |